340 related articles for article (PubMed ID: 33741967)
1. Immune suppressive activity of myeloid-derived suppressor cells in cancer requires inactivation of the type I interferon pathway.
Alicea-Torres K; Sanseviero E; Gui J; Chen J; Veglia F; Yu Q; Donthireddy L; Kossenkov A; Lin C; Fu S; Mulligan C; Nam B; Masters G; Denstman F; Bennett J; Hockstein N; Rynda-Apple A; Nefedova Y; Fuchs SY; Gabrilovich DI
Nat Commun; 2021 Mar; 12(1):1717. PubMed ID: 33741967
[TBL] [Abstract][Full Text] [Related]
2. IFNAR1 Controls Autocrine Type I IFN Regulation of PD-L1 Expression in Myeloid-Derived Suppressor Cells.
Xiao W; Klement JD; Lu C; Ibrahim ML; Liu K
J Immunol; 2018 Jul; 201(1):264-277. PubMed ID: 29752314
[TBL] [Abstract][Full Text] [Related]
3. Yeast-Derived Particulate β-Glucan Treatment Subverts the Suppression of Myeloid-Derived Suppressor Cells (MDSC) by Inducing Polymorphonuclear MDSC Apoptosis and Monocytic MDSC Differentiation to APC in Cancer.
Albeituni SH; Ding C; Liu M; Hu X; Luo F; Kloecker G; Bousamra M; Zhang HG; Yan J
J Immunol; 2016 Mar; 196(5):2167-80. PubMed ID: 26810222
[TBL] [Abstract][Full Text] [Related]
4. Distinct mechanisms govern populations of myeloid-derived suppressor cells in chronic viral infection and cancer.
Tcyganov EN; Hanabuchi S; Hashimoto A; Campbell D; Kar G; Slidel TW; Cayatte C; Landry A; Pilataxi F; Hayes S; Dougherty B; Hicks KC; Mulgrew K; Tang CA; Hu CA; Guo W; Grivennikov S; Ali MA; Beltra JC; Wherry EJ; Nefedova Y; Gabrilovich DI
J Clin Invest; 2021 Aug; 131(16):. PubMed ID: 34228641
[TBL] [Abstract][Full Text] [Related]
5. Plasticity of myeloid-derived suppressor cells in cancer.
Tcyganov E; Mastio J; Chen E; Gabrilovich DI
Curr Opin Immunol; 2018 Apr; 51():76-82. PubMed ID: 29547768
[TBL] [Abstract][Full Text] [Related]
6. Myeloid-derived suppressor cells confer tumor-suppressive functions on natural killer cells via polyinosinic:polycytidylic acid treatment in mouse tumor models.
Shime H; Kojima A; Maruyama A; Saito Y; Oshiumi H; Matsumoto M; Seya T
J Innate Immun; 2014; 6(3):293-305. PubMed ID: 24192491
[TBL] [Abstract][Full Text] [Related]
7. STAT3 inhibition induces Bax-dependent apoptosis in liver tumor myeloid-derived suppressor cells.
Guha P; Gardell J; Darpolor J; Cunetta M; Lima M; Miller G; Espat NJ; Junghans RP; Katz SC
Oncogene; 2019 Jan; 38(4):533-548. PubMed ID: 30158673
[TBL] [Abstract][Full Text] [Related]
8. Cancer-associated fibroblasts downregulate type I interferon receptor to stimulate intratumoral stromagenesis.
Cho C; Mukherjee R; Peck AR; Sun Y; McBrearty N; Katlinski KV; Gui J; Govindaraju PK; Puré E; Rui H; Fuchs SY
Oncogene; 2020 Sep; 39(38):6129-6137. PubMed ID: 32807917
[TBL] [Abstract][Full Text] [Related]
9. Suppression of Type I Interferon Signaling Overcomes Oncogene-Induced Senescence and Mediates Melanoma Development and Progression.
Katlinskaya YV; Katlinski KV; Yu Q; Ortiz A; Beiting DP; Brice A; Davar D; Sanders C; Kirkwood JM; Rui H; Xu X; Koumenis C; Diehl JA; Fuchs SY
Cell Rep; 2016 Apr; 15(1):171-180. PubMed ID: 27052162
[TBL] [Abstract][Full Text] [Related]
10. SPARC Is a New Myeloid-Derived Suppressor Cell Marker Licensing Suppressive Activities.
Sangaletti S; Talarico G; Chiodoni C; Cappetti B; Botti L; Portararo P; Gulino A; Consonni FM; Sica A; Randon G; Di Nicola M; Tripodo C; Colombo MP
Front Immunol; 2019; 10():1369. PubMed ID: 31281314
[TBL] [Abstract][Full Text] [Related]
11. Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment.
Ostrand-Rosenberg S; Fenselau C
J Immunol; 2018 Jan; 200(2):422-431. PubMed ID: 29311384
[TBL] [Abstract][Full Text] [Related]
12. Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs).
Alfaro C; Teijeira A; Oñate C; Pérez G; Sanmamed MF; Andueza MP; Alignani D; Labiano S; Azpilikueta A; Rodriguez-Paulete A; Garasa S; Fusco JP; Aznar A; Inogés S; De Pizzol M; Allegretti M; Medina-Echeverz J; Berraondo P; Perez-Gracia JL; Melero I
Clin Cancer Res; 2016 Aug; 22(15):3924-36. PubMed ID: 26957562
[TBL] [Abstract][Full Text] [Related]
13. CpG blocks immunosuppression by myeloid-derived suppressor cells in tumor-bearing mice.
Zoglmeier C; Bauer H; Noerenberg D; Wedekind G; Bittner P; Sandholzer N; Rapp M; Anz D; Endres S; Bourquin C
Clin Cancer Res; 2011 Apr; 17(7):1765-75. PubMed ID: 21233400
[TBL] [Abstract][Full Text] [Related]
14. Type I Interferon Signaling Is Required for CpG-Oligodesoxynucleotide-Induced Control of
Schleicher U; Liese J; Justies N; Mischke T; Haeberlein S; Sebald H; Kalinke U; Weiss S; Bogdan C
Front Immunol; 2018; 9():79. PubMed ID: 29459858
[TBL] [Abstract][Full Text] [Related]
15. 1α, 25 Dihydroxyvitamin D (1,25(OH)
Fleet JC; Burcham GN; Calvert RD; Elzey BD; Ratliff TL
J Steroid Biochem Mol Biol; 2020 Apr; 198():105557. PubMed ID: 31783150
[TBL] [Abstract][Full Text] [Related]
16. Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function.
Nam S; Kang K; Cha JS; Kim JW; Lee HG; Kim Y; Yang Y; Lee MS; Lim JS
J Leukoc Biol; 2016 Dec; 100(6):1273-1284. PubMed ID: 27601624
[TBL] [Abstract][Full Text] [Related]
17. TAM Family Receptor Kinase Inhibition Reverses MDSC-Mediated Suppression and Augments Anti-PD-1 Therapy in Melanoma.
Holtzhausen A; Harris W; Ubil E; Hunter DM; Zhao J; Zhang Y; Zhang D; Liu Q; Wang X; Graham DK; Frye SV; Earp HS
Cancer Immunol Res; 2019 Oct; 7(10):1672-1686. PubMed ID: 31451482
[TBL] [Abstract][Full Text] [Related]
18. Role of p38 protein kinase in the ligand-independent ubiquitination and down-regulation of the IFNAR1 chain of type I interferon receptor.
Bhattacharya S; Qian J; Tzimas C; Baker DP; Koumenis C; Diehl JA; Fuchs SY
J Biol Chem; 2011 Jun; 286(25):22069-76. PubMed ID: 21540188
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppressive effects and mechanisms of three myeloid-derived suppressor cells subsets including monocytic-myeloid-derived suppressor cells, granulocytic-myeloid-derived suppressor cells, and immature-myeloid-derived suppressor cells.
Nagatani Y; Funakoshi Y; Suto H; Imamura Y; Toyoda M; Kiyota N; Yamashita K; Minami H
J Cancer Res Ther; 2021; 17(4):1093-1100. PubMed ID: 34528569
[TBL] [Abstract][Full Text] [Related]
20. Type I IFN signaling in T regulatory cells modulates chemokine production and myeloid derived suppressor cells trafficking during EAE.
Tanwar S; Oguz C; Metidji A; Dahlstrom E; Barbian K; Kanakabandi K; Sykora L; Shevach EM
J Autoimmun; 2020 Dec; 115():102525. PubMed ID: 32709481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]